Page last updated: 2024-10-24

verapamil and Angiogenesis, Pathologic

verapamil has been researched along with Angiogenesis, Pathologic in 3 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research Excerpts

ExcerptRelevanceReference
" Low-dose chemotherapy, which is the long-term administration of relatively low doses of chemotherapeutic agents, has been proposed for targeting tumor angiogenesis in various types of cancers."1.42Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel. ( Akiyama, K; Alam, MT; Hida, K; Hida, Y; Kawamoto, T; Maishi, N; Ohba, Y; Ohga, N; Ohmura, H; Shindoh, M; Torii, C; Yamada, K, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xia, P1
Gou, WF1
Zhao, S1
Zheng, HC1
Akiyama, K1
Maishi, N1
Ohga, N1
Hida, Y1
Ohba, Y1
Alam, MT1
Kawamoto, T1
Ohmura, H1
Yamada, K1
Torii, C1
Shindoh, M1
Hida, K1
Wong, PP1
Demircioglu, F1
Ghazaly, E1
Alrawashdeh, W1
Stratford, MR1
Scudamore, CL1
Cereser, B1
Crnogorac-Jurcevic, T1
McDonald, S1
Elia, G1
Hagemann, T1
Kocher, HM1
Hodivala-Dilke, KM1

Other Studies

3 other studies available for verapamil and Angiogenesis, Pathologic

ArticleYear
Crizotinib may be used in Lewis lung carcinoma: a novel use for crizotinib.
    Oncology reports, 2013, Volume: 30, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcium Channel Blockers; Carcin

2013
Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.
    The American journal of pathology, 2015, Volume: 185, Issue:2

    Topics: Administration, Metronomic; Animals; Anti-Arrhythmia Agents; Antineoplastic Agents, Phytogenic; ATP

2015
Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
    Cancer cell, 2015, Jan-12, Volume: 27, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma,

2015